Blake Jeffrey Grayson Sells 8,000 Shares of DocuSign, Inc. (NASDAQ:DOCU) Stock

DocuSign, Inc. (NASDAQ:DOCUGet Free Report) CFO Blake Jeffrey Grayson sold 8,000 shares of the company’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $94.77, for a total value of $758,160.00. Following the transaction, the chief financial officer now owns 101,439 shares in the company, valued at $9,613,374.03. This trade represents a 7.31 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Blake Jeffrey Grayson also recently made the following trade(s):

  • On Tuesday, October 15th, Blake Jeffrey Grayson sold 9,552 shares of DocuSign stock. The stock was sold at an average price of $68.80, for a total transaction of $657,177.60.
  • On Wednesday, September 18th, Blake Jeffrey Grayson sold 14,036 shares of DocuSign stock. The stock was sold at an average price of $55.47, for a total transaction of $778,576.92.

DocuSign Price Performance

DOCU traded up $0.34 during midday trading on Tuesday, reaching $98.17. 3,797,399 shares of the company’s stock were exchanged, compared to its average volume of 2,996,714. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The stock has a market capitalization of $19.83 billion, a PE ratio of 20.24, a P/E/G ratio of 8.72 and a beta of 0.92. The business’s 50-day moving average price is $79.37 and its 200 day moving average price is $64.02.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on DOCU shares. JPMorgan Chase & Co. increased their price target on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research report on Tuesday, December 3rd. UBS Group lifted their price target on shares of DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Piper Sandler increased their price objective on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Robert W. Baird lifted their price objective on shares of DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Finally, Jefferies Financial Group raised their price target on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $92.45.

Check Out Our Latest Research Report on DocuSign

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Itau Unibanco Holding S.A. acquired a new position in DocuSign in the 3rd quarter valued at about $28,000. Brooklyn Investment Group acquired a new position in shares of DocuSign in the third quarter valued at approximately $33,000. Reston Wealth Management LLC purchased a new position in shares of DocuSign during the third quarter valued at approximately $47,000. Wilmington Savings Fund Society FSB purchased a new position in shares of DocuSign during the third quarter valued at approximately $51,000. Finally, nVerses Capital LLC acquired a new stake in DocuSign during the second quarter worth approximately $48,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.

About DocuSign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Further Reading

Insider Buying and Selling by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.